SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine

SRx Health Solutions (NYSE: SRXH) reported a +5.69% return in March 2026 for its hedging pool driven by the EMJX AI engine, versus a -4.98% decline for the S&P 500.

Rhea-AI Summary

SRx Health Solutions (NYSE: SRXH) reported a +5.69% return in March 2026 for its hedging pool driven by the EMJX AI engine, versus a -4.98% decline for the S&P 500. The company entered a definitive merger agreement with EMJ Crypto Technologies and intends to file a Form S-4 to register shares to be issued in the proposed transaction. The Board is considering a quarterly dividend based on a percentage of investment-portfolio profits. The company cautions investors to read the forthcoming Registration Statement and Information Statement/Prospectus.

Positive

• Definitive merger agreement signed with EMJ Crypto Technologies
• Hedging pool returned +5.69% in March 2026 versus S&P -4.98%

Negative

• Proposed issuance of common stock requires Form S-4 registration (potential dilution)
• Transaction contingent on SEC filings and approvals, creating timing and execution risk

Argus Apr 7 session

+16.33% close to close Open Argus

Details

News Market Reaction – SRXH

On Apr 7, the day this news came out, SRXH closed 16.33% above the previous close.

Data tracked by StockTitan Argus for the Apr 7 session.

Market Context

On Apr 7, the day this news came out, the stock closed 16.3% above the previous close. A strong posi...

Analysis

On Apr 7, the day this news came out, the stock closed 16.3% above the previous close. A strong positive reaction aligns with the company’s report of a +5.69% March hedging return against a -4.98% S&P 500 backdrop. Historically, AI-tagged announcements around EMJX and EventHorizonIQ saw average next-day moves of -4.56%, so a sharp gain would mark a departure from prior skepticism and could reflect growing confidence in the AI-driven portfolio strategy and merger path.

Key Figures

March 2026 hedging return: +5.69% S&P 500 March move: -4.98%

March 2026 hedging return

+5.69%

Return in SRx Health hedging pool driven by EMJX AI engine

S&P 500 March move

-4.98%

S&P 500 index performance in March 2026

Previous AI Reports

2 past events · Latest: Feb 06

Same Type 2 events

1. Feb 06

   AI platform launch

   24h Move

   -2.3%

   Launch of EventHorizonIQ ledger for AI-generated financial instability signals.

2. Dec 19

   AI integration update

   24h Move

   -6.9%

   Integration of OpenAI LLMs into Gen2 digital-asset treasury and QAM engine.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

artificial intelligence (ai), registration statement on form s-4, information statement/prospectus, securities act, +1 more

5 terms

artificial intelligence (ai) technical

"driven by the EMJX artificial intelligence (AI) engine as compared to a decline"

Artificial intelligence (AI) is the development of computer systems that can perform tasks typically requiring human intelligence, such as understanding language, recognizing patterns, and making decisions. For investors, AI can enhance how businesses analyze data, automate processes, and innovate, potentially leading to increased efficiency and new opportunities in the market.

registration statement on form s-4 regulatory

"EMJX intends to file with the SEC a Registration Statement on Form S-4"

A registration statement on Form S-4 is a formal filing with the U.S. Securities and Exchange Commission used when a company issues shares or other securities as part of a merger, acquisition, exchange offer or similar corporate deal. It bundles the transaction terms, financial statements, risk factors and shareholder vote materials so investors can assess the deal; think of it as a detailed prospectus or buyer’s packet that explains what you would own and how the deal could change your stake.

information statement/prospectus regulatory

"The Registration Statement will include an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus")"

A prospectus or information statement is a formal document that lays out key facts about a company, an offer of securities, or a proposed corporate action so investors can make informed choices. Think of it as a product label that explains what is being sold, the risks, the company’s finances and how proceeds will be used; investors rely on it to compare options and judge whether the potential reward justifies the risk.

securities act regulatory

"prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction"

A securities act is a law that governs the offering, sale and disclosure of stocks, bonds and other investment products to the public. It requires companies to provide clear, truthful information—like a product label for an investment—so buyers can understand risks and value before they invest. For investors, these rules reduce fraud, promote transparency, and help ensure fair access to market information.

prospectus regulatory

"No offer of securities shall be made except by means of a prospectus meeting the requirements"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index

SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio

NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index.

Michael Young, Director of SRx Health, commented, “Driven by the EMJX AI engine, we are pleased to return over 5% in March, while the broader market experienced a decline of approximately 5% amidst the ongoing global uncertainty. The Board of Directors is strongly considering implementing a quarterly dividend based on a percentage of profits from our investment portfolio.”

Additional Information and Where to Find It
In connection with the proposed transaction between the Company and EMJX intends to file with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement will include an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENTAND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.

No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What drove SRXH's +5.69% return in March 2026?

The return was driven by the EMJX artificial intelligence engine, producing portfolio gains in March. According to the company, the hedging pool returned +5.69% in March 2026 while the S&P 500 fell -4.98%, reflecting relative outperformance.

What does the SRXH definitive merger agreement with EMJX mean for shareholders?

It means SRXH plans to combine with EMJX under a binding agreement, subject to approvals. According to the company, a Registration Statement on Form S-4 will register common stock to be issued in the proposed transaction.

Will SRXH pay a quarterly dividend and when might it start?

The Board is considering a quarterly dividend tied to portfolio profits but has not fixed terms or a start date. According to the company, the dividend would be based on a percentage of investment-portfolio profits if approved.

How could the SRXH–EMJX transaction affect SRXH share count?

The transaction contemplates issuing common stock, which could increase outstanding shares and dilute existing holders. According to the company, shares to be issued will be registered via a Form S-4, subject to the registration process.

Where can SRXH investors find official documents about the proposed EMJX merger?

Investors can review SEC filings once available, including the Form S-4 and Information Statement/Prospectus. According to the company, those documents will be accessible free of charge on the SEC website when filed and declared effective.